<DOC>
	<DOC>NCT02269995</DOC>
	<brief_summary>This surveillance's objectives are: 1. Unknown adverse reactions 2. Incidences of adverse drug reaction 3. Factors considered to have effect to safety and effectiveness</brief_summary>
	<brief_title>Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>Inclusion criteria: Patients with Hepatocellular carcinoma Exclusion criteria:</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hepatocellular</keyword>
	<keyword>Carcinoma</keyword>
</DOC>